(Q24635226)

1

0 references

L Long

2

0 references

H Hörig

3

0 references

C Fairchild

4

0 references

P C Tyler

5

0 references

R H Furneaux

6

0 references

V L Schramm

7

0 references

H L Kaufman

Proceedings of the National Academy of Sciences of the United States of America

8

0 references

language of work or name

English

0 references

publication date

10 April 2001

0 references

published in

0 references

volume

98

0 references

issue

8

0 references

page(s)

4593-8

0 references

cites work

Cloning and expression of human deoxycytidine kinase cDNA

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=31879

Application of crystallographic and modeling methods in the design of purine nucleoside phosphorylase inhibitors

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=31879

Three-dimensional structure of human erythrocytic purine nucleoside phosphorylase at 3.2 A resolution

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=31879

One-third-the-sites transition-state inhibitors for purine nucleoside phosphorylase

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=31879

Erythrocyte metabolism in purine nucleoside phosphorylase deficiency after enzyme replacement therapy by infusion of erythrocytes

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=31879

The metabolism of deoxyguanosine and guanosine in human B and T lymphoblasts. A role for deoxyguanosine kinase activity in the selective T-cell defect associated with purine nucleoside phosphorylase deficiency

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=31879

Purinogenic immunodeficiency diseases: selective toxicity of deoxyribonucleosides for T cells

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=31879

Isolation and characterization of purine-nucleoside phosphorylase-deficient T-lymphoma cells and secondary mutants with altered ribonucleotide reductase: Genetic model for immunodeficiency disease

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=31879

Purine Nucleoside Phosphorylase Deficiency Associated with Selective Cellular Immunodeficiency

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=31879

Purine nucleoside phosphorylase. Catalytic mechanism and transition-state analysis of the arsenolysis reaction.

27 September 2017

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.071050798

Pre-steady-state transition-state analysis of the hydrolytic reaction catalyzed by purine nucleoside phosphorylase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.071050798

Synthesis of Transition State Analogue Inhibitors for Purine Nucleoside Phosphorylase and N-Riboside Hydrolases

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.071050798

Relationship of deoxycytidine kinase and cytoplasmic 5'-nucleotidase to the chemotherapeutic efficacy of 2-chlorodeoxyadenosine.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=31879

Enzymatic transition states and transition state analog design

28 November 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.071050798

In vivo and in vitro pharmacologic activity of the purine nucleoside phosphorylase inhibitor BCX-34: the role of GTP and dGTP

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.071050798

Roles of alternative synthetic and catabolic purine pathways in T lymphocyte differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.071050798

Protein properties of the subunits of ribonucleotide reductase and the specificity of the allosteric site(s)

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.071050798

Control of immune pathology by regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.071050798

IMMUNE RECONSTITUTION AFTER ALLOGENEIC BONE MARROW TRANSPLANTATION DEPLETED OF T CELLS

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.071050798

Methotrexate resistance in al L1210 cell line resulting from increased dihydrofolate reductase, decreased thymidylate synthetase activity, and normal membrane transport. Computer simulations based on network thermodynamics

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/11287638

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Common variable immunodeficiency and purine nucleotidase and nucleoside phosphorylase deficiency. A case report

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/11287638

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Regulation of purine metabolism by plasma membrane and cytoplasmic 5'-nucleotidases

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/11287638